Warby Parker (WRBY) Change in Accured Expenses (2020 - 2026)
Warby Parker (WRBY) posted Change in Accured Expenses of $12.2 million for Q1 2026, up 488.54% on a QoQ basis from -$3.1 million in Q4 2025, and up 2278.57% year-over-year from $512912.9 in Q1 2025.
Warby Parker (WRBY) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Warby Parker's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $12.2 million for Q1 2026.
- Quarterly Change in Accured Expenses rose 2278.57% year-over-year to $12.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (up 1927.4% YoY) and the FY2025 annual result came in at -$2.7 million, down 2618.18% from the prior year.
- Change in Accured Expenses was $12.2 million for Q1 2026 at Warby Parker, up from -$3.1 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $12.2 million in Q1 2026 and bottomed at -$7.8 million in Q1 2023.
- A 5-year average of $661882.4 and a median of -$239000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 221400.0% — and 2024, when it plunged 1026.29%.
- Warby Parker's Change in Accured Expenses stood at $2.2 million in 2022, then plunged by 111.33% to -$251000.0 in 2023, then plunged by 1026.29% to -$2.8 million in 2024, then declined by 11.07% to -$3.1 million in 2025, then soared by 488.54% to $12.2 million in 2026.
- Business Quant data shows WRBY's Change in Accured Expenses at $12.2 million in Q1 2026, -$3.1 million in Q4 2025, and $84000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 125.56 Bn | 120.35 Bn | 1.96 Bn | -260.40 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | - |
| 3 | Alcon | 33.08 Bn | 31.43 Bn | 1.53 Bn | - |
| 4 | Medline | 32.76 Bn | 30.53 Bn | 1.84 Bn | -32.00 Mn |
| 5 | Resmed | 29.25 Bn | 27.59 Bn | 890.98 Mn | 103.88 Mn |
| 6 | West Pharmaceutical Services | 23.67 Bn | 23.24 Bn | 329.20 Mn | - |
| 7 | Solventum | 13.99 Bn | 13.43 Bn | 1.10 Bn | -151.00 Mn |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 5.38 Mn |
| 10 | Warby Parker | 3.09 Bn | 2.80 Bn | 131.04 Mn | 12.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.20 Mn |
| Mar 31, 2026 | 12.20 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Sep 30, 2025 | 84,000.00 |
| Sep 30, 2025 | 84,000.00 |
| Jun 30, 2025 | 925,000.00 |
| Jun 30, 2025 | 925,000.00 |
| Mar 31, 2025 | -560,000.00 |
| Mar 31, 2025 | -560,000.00 |
| Dec 31, 2024 | -2.83 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | -469,000.00 |
| Jun 30, 2024 | -469,000.00 |
| Mar 31, 2024 | -108,000.00 |
| Mar 31, 2024 | -108,000.00 |
| Dec 31, 2023 | -251,000.00 |
| Dec 31, 2023 | -251,000.00 |